Answers are grounded in this paper and cite their sources.
This article reviews the evidence supporting the emerging view that 1) indirect responses play an important role in allograft rejection, 2) a limited number of major histocompatibility complex peptides are critical for stimulating indirect responses, and 3) major histocompatibility complex peptide therapy might, therefore, be useful in preventing allograft rejection.
No takes yet. Share an insight, caveat, or question.
Chitilian et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: